RxDoctor Payments Data

Elise Barrett, MD

Family Medicine · Houston, TXNPI 1871733121

Payments from drug & device makers

$955in general payments, 2019–2025

Across 44 payments — averaging $21.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$122
  • Exact Sciences$111
  • Organon$92
  • AbbVie$69
  • Novo Nordisk$65
  • AstraZeneca$65
  • plus $430 from 17 others

What the payments were for

  • Food & beverage$93498%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$955 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$12,653
Medicare patients
68
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide28$35,168
FarxigaDapagliflozin Propanediol22$29,238
MounjaroTirzepatide18$18,428
Novolog FlexpenInsulin Aspart12$1,593
Gabapentin82$1,210
Albuterol Sulfate HfaAlbuterol Sulfate48$868
Levothyroxine Sodium65$631
Celecoxib35$588
Rosuvastatin Calcium61$490
Duloxetine Hcl15$443
Potassium Chloride18$433
Atorvastatin Calcium56$432
Trazodone Hcl44$403
Ropinirole Hcl14$397
Pregabalin20$385

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$65$35,16828 claims
AstraZenecaFarxiga$65$29,23822 claims
Lilly USA, LLCMounjaro$52$18,42818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →